Home/ Supplements/ Omega 3/ Omega 3-6-9

Omega 3-6-9

product on market Softgel Capsule Micro Ingredients Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Omega 3-6-9
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
100
Servings
Fat/Fatty Acid
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
36 Calorie(s)
Calories from Fat
36 Calorie(s)
Total Fat
3.6 Gram(s) (5% DV)
Cholesterol
10 mg (3% DV)
Protein
1 Gram(s) (1% DV)

Other Ingredients

kosher Gelatin Glycerin purified Water
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take 3 softgels with meal daily. For best results, please consult your physician.

Warnings & Precautions

Keep out of the reach of children.

If pregnant/lactating or taking any medications, please consult your physician prior to use.

Formulation Notes

Soy Non-GMO No gluten

Free of: soy, dairy, yeast, gluten, corn.

Additional Information

Keep in a cool, dry place.

Metadata

Product Details

UPC / SKUX002585LJB
DSLD Entry Date2020-08-23
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID231841
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.